Company page
Ascletis Pharma, Inc.
Ascletis Pharma, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 1672. The company has a market capitalization of approximately HKD 1.32 billion. Ascletis focuses on the development and commercialization of innovative therapies for the treatment of liver diseases and cancer.
- Ticker
- 1672:HKEX
- Asset type
- Stock
- Market cap
- $1.32B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD